Scribd Logo
Upload

Welcome to Scribd!

  • Lilly Industry Comp

    Uploaded by

    nvkulkarni
    30 views6 pages
    This document provides an overview of Eli Lilly and Company, a large global pharmaceutical company. It describes Lilly's major business segments which include neuroscience, diabetes, oncology, and other products. It also lists some of Lilly's top competitors and compares their key financial metrics. Finally, it discusses trends in the pharmaceutical industry including continued demand, cost pressures from generics and insurance, and employment outlook.

    Original Description:

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PPT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document provides an overview of Eli Lilly and Company, a large global pharmaceutical company. It describes Lilly's major business segments which include neuroscience, diabetes, oncology, and other products. It also lists some of Lilly's top competitors and compares their key financial metrics. Finally, it discusses trends in the pharmaceutical industry including continued demand, cost pressures from generics and insurance, and employment outlook.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    30 views6 pages

    Lilly Industry Comp

    Uploaded by

    nvkulkarni
    This document provides an overview of Eli Lilly and Company, a large global pharmaceutical company. It describes Lilly's major business segments which include neuroscience, diabetes, oncology, and other products. It also lists some of Lilly's top competitors and compares their key financial metrics. Finally, it discusses trends in the pharmaceutical industry including continued demand, cost pressures from generics and insurance, and employment outlook.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 6

    Eli Lilly and Company

    Introduction
    • Company Description
    • Value Chain
    • Five Force Analysis
    • Balance Scorecard

    2
    Company Description
    10th Largest Global Pharmaceutical
    Ticker: LLY
    Indianapolis, Indiana
    Founded 1876
    ~40,000 Employees
    Worldwide R&D, Manufacturing & Clinical Trials
    R&D Investment = 20% of Revenue
     $17 Million per working day!

    3
    Major Products
    Neuroscience (schizophrenia, depression etc.)

    Diabetes Osteoporosis

    Oncology (pancreatic, breast, lung, ovarian & bladder cancer treatments)


    Other (Cattle Feed Additives, Dairy Protein Supplements, Parasiticides, Antibiotics)

    4
    Competitors
    • Healthcare Sector  Major Drug Manufacturers

    LLY GSK NVO PFE

    Market Cap: 37.97B 94.42B 42.34B 142.02B

    Employees: N/A N/A 28,809 120,700

    Revenue: 21.84B 43.23B 9.35B 50.01B

    Gross Margin: 80.55% 74.99% 79.56% 82.52%

    Oper Margins: 29.17% 27.37% 29.24% 31.85%

    Net Income: 4.33B 8.43B 1.97B 8.62B

    EPS: 3.941 3.3 3.26 1.226

    5
    Industry Outlook
    • Continued Strong Demand
    – Expanding population, longer lifespan
    – “Lifestyle” Drugs
    • Cost Pressures
    – Patent Expirations
    – Competition from generics
    – Current Health Insurance Trends  Greater Employee Responsibility – Cost Sharing
    • Employment
    – Fairly “recession” proof
    – Strong R&D focus favors – scientists, Ph.D’s

    You might also like